EUVIMEDEUVIMED entdecken
Crossref

Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection

Will Vuyk, Max Bobholz, Isla Emmen, Andrew Lail, Nicholas Minor, Pavan Bhimalli, Jens C Eickhoff, Hunter J Ries, Heather Machkovech, Wanting Wei, Andrea Weiler, Alex Richardson und 16 weitere

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.04.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Will Vuyk und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Organ Transplantation, Immunocompromised Host. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Centers for Disease Control and Prevention, Department of Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Compared with immunocompetent individuals, those who are immunocompromised, including solid organ transplant (SOT) recipients, have higher SARS-CoV-2-related morbidity and mortality. We determined the duration of SARS-CoV-2 RNA positivity to evaluate viral persistence in SOT recipients. METHODS: This study prospectively followed SOT recipients who recently tested positive for SARS-CoV-2. The duration of viral RNA shedding in nasal swabs and stool samples was tracked, and viral genome sequencing was performed where possible. Persistent infection was defined as a positive nucleic acid amplification test (NAAT) for SARS-CoV-2 at 28 days or later after initial infection. This duration was chosen based on the U.S. Centers for Disease Control and Prevention (CDC) recommendation that immunocompromised individuals isolate for at least 20 days [1], compared with 10 days for non-immunocompromised individuals. RESULTS: Of 30 SOT recipients, 12 (40%) had positive SARS-CoV-2 RNA in nasal swabs or stool (cycle threshold [Ct] < 40) at 28 or more days after the first positive SARS-CoV-2 test. Immunocompromised (IC) subject 015 had high viral loads (Ct < 30) at 28 days, with continued detection for 54 days. CONCLUSIONS: In 12 of 30 SOT subjects, SARS-CoV-2 RNA was detected at or beyond 28 days post-detection (dpd), despite vaccination and antibody and/or antiviral treatment in most participants. Three subjects tested positive for SARS-CoV-2 RNA past 50 dpd. Viral persistence in the setting of host immune suppression, coupled with exposure to antiviral treatments, raises concern about the selection of unusual viral variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Organ TransplantationImmunocompromised HostTransplant RecipientsHumansMiddle AgedMaleFemaleVirus SheddingProspective StudiesAdultRNA, ViralLongitudinal StudiesViral LoadAgedFeces

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
  • Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin.
  • Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
  • Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
  • Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
  • Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.

Förderung

  • Centers for Disease Control and Prevention
  • Department of Surgery

Zitieren

APA

Vuyk, W., Bobholz, M., Emmen, I., Lail, A., Minor, N., Bhimalli, P., Eickhoff, J. C., Ries, H. J., Machkovech, H., Wei, W., Weiler, A., Richardson, A., DePagter, C., VanSleet, G., Bhasin, M., Kamal, S., Wolf, S., Virdi, A., Bradley, T., …, & Garonzik-Wang, J. (2025). Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.04.004

Vancouver

Vuyk W, Bobholz M, Emmen I, Lail A, Minor N, Bhimalli P, et al. Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.04.004

BibTeX
@article{Vuyk2025,
  author = {Vuyk, Will and Bobholz, Max and Emmen, Isla and Lail, Andrew and Minor, Nicholas and Bhimalli, Pavan and Eickhoff, Jens C and Ries, Hunter J and Machkovech, Heather and Wei, Wanting and Weiler, Andrea and Richardson, Alex and DePagter, Carson and VanSleet, Grace and Bhasin, Maansi and Kamal, Sarah and Wolf, Sydney and Virdi, Aanya and Bradley, Taylor and Gifford, Angela and Benito, Melanie and Shipe, Alex and Mohamed, Rana and Smith, Jeannina and Wilson, Nancy and Friedrich, Thomas C and O'Connor, David H and Garonzik-Wang, Jacqueline},
  title = {Longitudinal Assessment of Solid Organ Transplant Recipients With SARS-CoV-2 Infection},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.04.004}
}
Kostenlos starten →